• Advanced Paternal Age and Early Onset of Schizophrenia in Sporadic Cases: Not Confounded by Parental Polygenic Risk for Schizophrenia

      Wang, Shi-Heng; Hsiao, Po-Chang; Yeh, Ling-Ling; Liu, Chih-Min; Liu, Chen-Chung; Hwang, Tzung-Jeng; Hsieh, Ming H.; Chien, Yi-Ling; Lin, Yi-Ting; Huang, Yen-Tsung; et al. (Elsevier BV, 2019-07)
      BACKGROUND:Whether paternal age effect on schizophrenia is a causation or just an association due to con-founding by selection into late parenthood is still debated. We investigated the association between paternal age andearly onset of schizophrenia in offspring, controlling for both paternal and maternal predisposition to schizophrenia asempirically estimated using polygenic risk score (PRS) derived from the Psychiatric Genomics Consortium.METHODS:Among 2923 sporadic schizophrenia cases selected from the Schizophrenia Trio Genomic Research inTaiwan project, 1649 had parents’genotyping data. The relationships of paternal schizophrenia PRS to paternal ageatfirst birth (AFB) and of maternal schizophrenia PRS to maternal AFB were examined. A logistic regression model ofpatients’early onset of schizophrenia (#18 years old) on paternal age was conducted.RESULTS:Advanced paternal age over 20 years exhibited a trend of an increasing proportion of early onset ofschizophrenia (odds ratio per 10-year increase in paternal age = 1.28,p= .007) after adjusting for maternal age, sex,and age. Older paternal AFB also exhibited an increasing trend of paternal schizophrenia PRS. Additionally, aU-shaped relationship between maternal AFB and maternal schizophrenia PRS was observed. After adjusting forboth paternal and maternal schizophrenia PRS, the association of paternal age with patients’early onset ofschizophrenia remained (odds ratio = 1.29,p= .04).CONCLUSIONS:The association between paternal age and early onset of schizophrenia was not confounded byparental PRS for schizophrenia, which partially captures parental genetic vulnerability to schizophrenia. Ourfindingssupport an independent role of paternal age per se in increased risk of early onset of schizophrenia in offspring
    • Genome-wide association study of response to methylphenidate in 187 children with attention-deficit/hyperactivity disorder

      Mick, Eric; Neale, Benjamin; Middleton, Frank A.; McGough, James J.; Faraone, Stephen V. (Wiley, 2008-12-05)
      We conducted a genome-wide association study of symptom response in an open-label study of a methylphenidate transdermal system (MTS). All DNA extraction and genotyping was conducted at SUNY Upstate Medical University using the Affymetrix Genome-Wide Human SNP Array 6.0. All quality control and association analyses were conducted using the software package PLINK. After data cleaning and quality control, there were 187 subjects (72% (N¼135) male) with mean age 9.2 2.0 years and 319,722 SNPs available for analysis. The most statistically significant association (rs9627183 andrs11134178;P¼3 10 6) fell short of the threshold for a genome-wide significant association. The most intriguing association amongsuggestivefindings(rs3792452;P¼2.6 10 5) was with the metabotropic glutamate receptor 7 gene (GRM7) as it is expressed in brain structures also previously associated with ADHD. Among the 102 available SNPs covering previously studied candidate genes, two SNPs within the norepinephrine transporter gene (NET, SLC6A2) were significant at P 1 10 2. These results should be considered preliminary until replicated in larger adequately powered, controlled samples but do suggest that noradrenergic and possibly glutaminergic genes may be involved with response to methylphenidate.